logo
  

Nektar Therapeutics Q3 Earnings Summary

Below are the earnings highlights for Nektar Therapeutics (NKTR):

-Earnings: -$129.71 million in Q3 vs. -$108.59 million in the same period last year.
-EPS: -$0.70 in Q3 vs. -$0.61 in the same period last year.
-Analysts projected -$0.80 per share
-Revenue: $24.92 million in Q3 vs. $30.03 million in the same period last year.

For comments and feedback contact: editorial@rttnews.com

RELATED NEWS
Follow RTT